Table. 2—

Results of pulmonary function tests in 14 patients with necrotising sarcoid granulomatosis

Patient No.FEV1 L (% pred)FVC L (% pred)FEV1/FVC % predTLC L (% pred)RV L (% pred)RV/TLC % predDL,CO/VA % pred
13.1 (118)3.9 (125)805.2 (110)1.3 (85)2574
22.6 (80)3.0 (80)825.6 (104)2.6 (160)46105
32.8 (82)3.1 (92)864.3 (82)1.1 (82)26109
43.8 (102)4.7 (101)826.3 (88)1.1 (52)1874
52.6 (111)3.0 (109)865.0 (99)2.1 (110)4274
62.3 (78)3.0 (80)765.4 (83)1.7 (95)3178
73.1 (88)3.2 (89)954.3 (91)1.1 (109)2583
83.3 (116)3.4 (95)966.2 (98)2.8 (116)4560
92.3 (80)2.7 (83)844.1 (85)1.3 (87)3274
102.2 (91)2.6 (101)764.3 (103)1.4 (90)32NA
112.1 (91)2.6 (95)815.5 (106)2.1 (101)38NA
121.8 (52)2.7 (62)695.2 (79)2.7 (134)5274
133.0 (110)3.5 (113)866.1 (123)2.6 (150)4371
143.5 (84)3.9 (74)84NANANANA
  • FEV1: forced expiratory volume in one second; % pred: percentage of predicted; FVC: forced vital capacity; TLC: total lung capacity; RV: residual volume; DL,CO: carbon monoxide diffusing capacity of the lung; VA: alveolar volume; NA: not available.